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The proton-pumping NADH:ubiquinone oxidoreductase (com-
plex I), the ﬁrst complex of the respiratory chains, couples the
transfer of electrons from NADH to ubiquinone with the transloca-
tion of protons across the membrane. The soluble NADH
dehydrogenase fragment represents the electron input part of
complex I and comprises 3 subunits, one ﬂavin mononucleotide
and up to six iron–sulfur clusters. Previous electron microscopic
studies revealed NADH induced large conformational changes for
complex I. Structural information on the soluble fragment about
these changes are not available. ATR-FTIR spectroscopic investiga-
tions of the conformational change of the NADH dehydrogenase
fragment in the presence and absence of NADH substrate have
been applied. The secondary structure determination was based on
the analysis of the intense amide I band between 1710 to 1600 cm−1
which predominantly includes the C=O stretching vibration of the
protein backbone. The highly organized α helical and β sheet
components are negligibly altered upon NADH addition whereas
variations for turns and random elements are obtained. During
perfusion-induced investigations an increase of the amide I and
amide II are observed which indicates a conformational change upon
NADH binding. Furthermore, investigations on the whole complex I
are presented.
doi:10.1016/j.bbabio.2008.05.152
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An effective method was developed for isolation and analysis
of bovine heart Complex I subunits. The method utilizes C18
reversed-phase HPLC and a water:acetonitrile gradient contain-
ing 0.1% triﬂuoroacetic acid. Employing this system, 36 of the 45
Complex I subunits eluted in 28 distinct chromatographic peaks.
Nine subunits did not elute including B14.7, MLRQ and the seven
mitochondrial-encoded subunits. The method, with UV detec-
tion, is suitable for either analytical (b50 μg protein) or
preparative (N250 μg protein) applications. Subunit(s) eluting
in each chromatographic peak were initially determined by
MALDI-TOF/MS with subsequent positive identiﬁcation by
reversed-phase HPLC-ESI/MS/MS analysis of tryptic digests. In
the latter case, subunits were identiﬁed with a 99% probability
using Scaffold analysis software combined with a X! Tandem
protein search engine. The RP-HPLC subunit analysis method
represents a major improvement over previous separation
methods with respect to resolution, simplicity and ease of
application. As expected, the HPLC method, combined with mass
spectrometry analysis is capable of detecting oxidatively
damaged subunits after in vitro exposure of Complex I to
peroxynitrite. The results of these experiments will help
elucidate the chemical nature of oxidative damage to this key
electron transport chain component. Supported by NIH GMS
(24795) and Welch Foundation (AQ1481).
doi:10.1016/j.bbabio.2008.05.153
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The proton-pumping NADH:ubiquinone oxidoreductase (com-
plex I) is the ﬁrst complex of the respiratory chains in many
bacteria and most eukaryotes. It is the least understood respiratory
complex, due to its size and intricate assembly. Complex I of the
hyperthermophilic bacterium Aquifex aeolicus is made up of 13
different subunits named NuoA2–N1. The ﬂavoprotein subcomplex
contains subunits NuoE and F and is considered as the simplest
catalytically active NADH dehydrogenase. It harbours one FMN, the
binuclear iron–sulfur cluster N1a and the tetranuclear cluster N3 as
well as the NADH binding site. This subcomplex was heterologously
overproduced in Escherichia coli and isolated by standard chroma-
tographic techniques. The proteins of the preparation were
identiﬁed as NuoE and NuoF by N-terminal sequencing and mass
spectrometry. The expected cofactors of the preparation were
detected by EPR- and UV/vis spectroscopy. The preparation is
thermostable and catalyzes NADH/ferricyanide oxidoreductase
activity at temperatures up to 85 °C. Furthermore, the preparation
is homogenous as shown by dynamic light scattering and meets all
prerequisites for crystallization attempts.
doi:10.1016/j.bbabio.2008.05.154
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The respiratory chain of the human malaria parasite Plasmodium
falciparum lacks a canonical protonmotive NADH:ubiquinone oxi-
doreductase (Complex I), containing instead a single-subunit, non-
protonmotive Ndh2, similar to that found in plant mitochondria,
fungi and some bacteria. As such, the P. falciparum Ndh2 (PfNdh2)
presents itself as an attractive anti-malarial chemotherapeutic
target, and we have developed a structural model and heterologous
expression system for this enzyme to facilitate its physicochemical
and enzymological characterisation. Structural modelling of PfNdh2
suggests the presence of two Rossman folds forming the ﬂavin and
NADH binding sites, with membrane attachment via a C-terminal
amphipathic helix. Heterologous expression of PfNdh2 in E.coli
NADH dehydrogenase knockout strain ANN0222 yields an active
enzyme with Km values for NADH and decylubiquinone of 14- and
12 μM respectively in crude membrane preparations. In addition,
the recombinant PfNdh2 is strongly inhibited by 1-hydroxy-2-
dodecyl-4(1H)quinolone (IC50=70 nM in crude membrane pre-
parations) with decylubiquinone as substrate. Puriﬁcation of His-
tagged PfNdh2 for high throughput drug screening, stopped-ﬂow
spectrophotometry and NMR/FTIR spectroscopic investigation is
currently underway.
doi:10.1016/j.bbabio.2008.05.155
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